Kathi Niffenegger
2020
In 2020, Kathi Niffenegger earned a total compensation of $505.3K as Chief Financial Officer at Edesa Biotech, a 313% increase compared to previous year.
Compensation breakdown
| Bonus | $31,354 |
|---|---|
| Option Awards | $214,275 |
| Salary | $234,069 |
| Other | $25,613 |
| Total | $505,311 |
Niffenegger received $234.1K in salary, accounting for 46% of the total pay in 2020.
Niffenegger also received $31.4K in bonus, $214.3K in option awards and $25.6K in other compensation.
Rankings
In 2020, Kathi Niffenegger's compensation ranked 10,994th out of 13,090 executives tracked by ExecPay. In other words, Niffenegger earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,994 out of 13,090 | 16th |
Division Manufacturing | 4,695 out of 5,620 | 17th |
Major group Chemicals And Allied Products | 1,951 out of 2,253 | 13th |
Industry group Drugs | 1,707 out of 1,953 | 13th |
Industry Pharmaceutical Preparations | 1,262 out of 1,458 | 13th |
Source: SEC filing on March 3, 2021.
Niffenegger's colleagues
We found two more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2020.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020